Milestone Scientific Inc. (NYSEAMERICAN:MLSS) Director Sells $11,023.04 in Stock

Milestone Scientific Inc. (NYSEAMERICAN:MLSSGet Rating) Director Leonard Osser sold 9,842 shares of the firm’s stock in a transaction dated Monday, April 18th. The stock was sold at an average price of $1.12, for a total value of $11,023.04. Following the transaction, the director now owns 4,225,596 shares of the company’s stock, valued at $4,732,667.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Leonard Osser also recently made the following trade(s):

  • On Monday, April 11th, Leonard Osser sold 8,200 shares of Milestone Scientific stock. The stock was sold at an average price of $1.21, for a total value of $9,922.00.
  • On Monday, April 4th, Leonard Osser sold 14,100 shares of Milestone Scientific stock. The stock was sold at an average price of $1.42, for a total value of $20,022.00.
  • On Friday, April 1st, Leonard Osser sold 6,000 shares of Milestone Scientific stock. The stock was sold at an average price of $1.51, for a total value of $9,060.00.
  • On Monday, March 28th, Leonard Osser sold 7,110 shares of Milestone Scientific stock. The stock was sold at an average price of $1.33, for a total value of $9,456.30.
  • On Monday, March 21st, Leonard Osser sold 7,600 shares of Milestone Scientific stock. The stock was sold at an average price of $1.30, for a total value of $9,880.00.
  • On Monday, March 14th, Leonard Osser sold 8,100 shares of Milestone Scientific stock. The stock was sold at an average price of $1.23, for a total value of $9,963.00.
  • On Monday, March 7th, Leonard Osser sold 6,400 shares of Milestone Scientific stock. The stock was sold at an average price of $1.53, for a total value of $9,792.00.
  • On Monday, February 28th, Leonard Osser sold 7,500 shares of Milestone Scientific stock. The stock was sold at an average price of $1.33, for a total value of $9,975.00.
  • On Tuesday, February 22nd, Leonard Osser sold 7,700 shares of Milestone Scientific stock. The stock was sold at an average price of $1.28, for a total value of $9,856.00.
  • On Monday, February 14th, Leonard Osser sold 8,400 shares of Milestone Scientific stock. The stock was sold at an average price of $1.19, for a total value of $9,996.00.

Shares of Milestone Scientific stock opened at $1.08 on Friday. Milestone Scientific Inc. has a 52 week low of $1.07 and a 52 week high of $3.17. The company has a market capitalization of $73.57 million, a price-to-earnings ratio of -12.00 and a beta of 1.34.

Milestone Scientific (NYSEAMERICAN:MLSSGet Rating) last posted its earnings results on Friday, April 1st. The medical instruments supplier reported ($0.02) earnings per share for the quarter. Milestone Scientific had a negative net margin of 79.28% and a negative return on equity of 39.43%. The company had revenue of $2.85 million during the quarter. Equities research analysts expect that Milestone Scientific Inc. will post -0.1 EPS for the current fiscal year.

Hedge funds have recently bought and sold shares of the company. Virtu Financial LLC bought a new position in shares of Milestone Scientific in the fourth quarter valued at approximately $31,000. Barclays PLC lifted its holdings in Milestone Scientific by 475.6% during the fourth quarter. Barclays PLC now owns 40,842 shares of the medical instruments supplier’s stock worth $84,000 after acquiring an additional 33,747 shares during the period. Oppenheimer & Co. Inc. boosted its position in Milestone Scientific by 26.7% in the fourth quarter. Oppenheimer & Co. Inc. now owns 47,500 shares of the medical instruments supplier’s stock worth $98,000 after purchasing an additional 10,000 shares during the last quarter. State Street Corp boosted its position in Milestone Scientific by 83.9% in the fourth quarter. State Street Corp now owns 87,700 shares of the medical instruments supplier’s stock worth $181,000 after purchasing an additional 40,000 shares during the last quarter. Finally, BlackRock Inc. boosted its position in Milestone Scientific by 141.0% in the third quarter. BlackRock Inc. now owns 198,352 shares of the medical instruments supplier’s stock worth $371,000 after purchasing an additional 116,045 shares during the last quarter. Institutional investors own 8.82% of the company’s stock.

A number of equities research analysts have commented on MLSS shares. Maxim Group reduced their price objective on Milestone Scientific from $6.00 to $4.00 in a research note on Monday, April 4th. Zacks Investment Research raised Milestone Scientific from a “sell” rating to a “hold” rating in a research note on Wednesday, January 5th.

About Milestone Scientific (Get Rating)

Milestone Scientific, Inc develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns.

Read More

Insider Buying and Selling by Quarter for Milestone Scientific (NYSEAMERICAN:MLSS)

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.